Post EVAR Endoleak Detection Clinical Trial
Official title:
Post EVAR Endoleak Detection : Model-based Iterative Reconstruction (MBIR) vs Adaptive Statistical Iterative Reconstruction (ASIR) CTA; a Prospective Study
Verified date | March 2014 |
Source | University Hospital, Clermont-Ferrand |
Contact | n/a |
Is FDA regulated | No |
Health authority | France: Ministry of Health |
Study type | Interventional |
The purpose of the study is to compare the accuracy of the diagnosis of endoleak in patient with EVAR comparing Adaptive statistical iterative reconstruction (ASIR) CTA and Model-based iterative reconstruction (MBIR- VEO TM).
Status | Completed |
Enrollment | 90 |
Est. completion date | February 2014 |
Est. primary completion date | February 2014 |
Accepts healthy volunteers | No |
Gender | Both |
Age group | 18 Years to 90 Years |
Eligibility |
Inclusion Criteria: - informed and a written consent - all patients consulting to follow up his EVAR - 18-90 years - French Exclusion Criteria: - pregnant - juvenile patients - patient who refusal the study - CI of contrast iodine injection : CI of ultravist - llergy - renal failure creatinemy <30 ml/min |
Allocation: Non-Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Diagnostic
Country | Name | City | State |
---|---|---|---|
France | CHU de Clermont-Ferrand | Clermont-Ferrand |
Lead Sponsor | Collaborator |
---|---|
University Hospital, Clermont-Ferrand |
France,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Presence or absence of endoleak after EVAR using CT evaluation | at day 1 | Yes | |
Secondary | Type of endoleak, BMI (body mass index | at day 1 | Yes | |
Secondary | Diameter of the aneurysm | at day 1 | Yes | |
Secondary | Objective and subjective image quality | at day 1 | Yes |